Table 1.
Patients and tumor characteristics.
| Parameter | n |
|---|---|
| Patients | 53 |
| Age at radiation, mean (year), (range) | 62 (27–92) |
| Histology | |
| IDC | 36 (68%) |
| ILC | 3 (5.6%) |
| Other/unknown | 14 (26.4%) |
| Hormonal status | |
| ER positive | 40 (75.4%) |
| PR positive | 15 (28.3%) |
| HER2 positive | 17 (32%) |
| Triple negative | 5 (9%) |
| Stage at diagnosis | |
| Local | 21 (40%) |
| Metastatic | 32 (60%) |
| Previous adjuvant breast radiation | 9 (16.9%) |
| Time from diagnosis to palliative radiation, median (m), (range) | 23 (0–72) |
| Tumor characteristic | |
| Size | |
| Mean | 6.3 cm |
| < 4 cm | 6 (11%) |
| 4–9 cm | 31 (58.2%) |
| > 9 cm | 9 (16.9%) |
| Unknown | 7 (13.2%) |
| Skin involvement | 32 (60%) |
| Symptomsa | |
| Discomfort | 53 (100%) |
| Pain | 45 (84%) |
| Ulceration | 26 (49%) |
| Discharge | 23 (43%) |
| Bleeding | 16 (30%) |
| Malodor | 12 (23%) |
| Chemotherapy during palliative radiation | 13 (24%) |
aSome patients had more than one symptom.